Alto Neuroscience, Inc. (NYSE:ANRO) has 109 institutional investors with active 13F positions as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Alpha Wave Global, LP | 31 Mar, 2026 | 3,707,757 | 0 | 0.00% | $83,350,377.00 |
| Commodore Capital LP | 31 Mar, 2026 | 2,723,196 | 900,000 | 49.36% | $61,217,446.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 2,064,075 | -420,925 | -16.94% | $46,400,406.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 2,009,893 | 225,500 | 12.64% | $45,182,395.00 |
| Spruce Street Capital LP | 31 Mar, 2026 | 1,325,210 | 1,102,366 | 494.68% | $29,116,321.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,207,025 | 1,207,025 | 0.00% | $27,133,922.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 1,101,874 | -17,704 | -1.58% | $24,770,128.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 1,035,551 | 0 | 0.00% | $23,279,186.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 912,000 | -624,000 | -40.63% | $20,501,760.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 821,982 | 191,997 | 30.48% | $18,478,155.00 |
| 72 Investment Holdings, LLC | 31 Mar, 2026 | 667,778 | 0 | 0.00% | $15,011,649.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 666,188 | 58,314 | 9.59% | $14,975,907.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 515,000 | 0 | 0.00% | $11,577,200.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 503,087 | -1,103,867 | -68.69% | $11,309,396.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 500,000 | 500,000 | 0.00% | $11,240,000.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 500,000 | 500,000 | 0.00% | $11,240,000.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 500,000 | 125,000 | 33.33% | $11,240,000.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 486,726 | 149,964 | 44.53% | $10,942,410.00 |
| Northern Trust Corp | 31 Mar, 2026 | 473,403 | -970 | -0.20% | $10,642,099.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 386,426 | 386,426 | 0.00% | $8,686,856.00 |